Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s stock price shot up 1.8% during mid-day trading on Friday . The company traded as high as GBX 30 ($0.38) and last traded at GBX 28 ($0.35). 7,615 shares were traded during mid-day trading, a decline of 90% from the average session volume of 77,203 shares. The stock had previously closed at GBX 27.50 ($0.35).
Celadon Pharmaceuticals Trading Up 1.8 %
The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 194.82. The company has a 50-day moving average price of GBX 31.53 and a 200 day moving average price of GBX 56.28. The stock has a market capitalization of £19.28 million, a P/E ratio of -350.00 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Celadon Pharmaceuticals
- What is the S&P 500 and How It is Distinct from Other Indexes
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Best Stocks Under $5.00
- Top-Performing Non-Leveraged ETFs This Year
- How to Calculate Inflation Rate
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
